New drug with OMRF roots reduces pain in sickle cell disease.
Adakveo significantly reduces pain crises in sickle cell patients.
Scientists at OMRF have made new findings that could pave the way for the first drug to treat aortic stenosis.
The scholars were selected from a pool of 70 applicants from across the state.
High school seniors, as well as college freshmen, sophomores and juniors, are eligible to apply.
For Mary Long, the answer to her pain may, literally, be right around the corner.